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Objectives. This study sought to determine the ability of early
perfusion imaging using technetium-99m sestamibi to predict
adverse cardiac outcomes in patients who present to the emer-
gency department with possible cardiac ischemia and nondiag-
nostic electrocardiograms (ECGs).
Background. Evaluation of patients presenting to the emer-
gency department with possible acute coronary syndromes and
nondiagnostic ECGs is problematic. Accurate risk stratification is
necessary to prevent serious adverse outcomes. Initial results
suggest that early perfusion imaging using technetium-99m ses-
tamibi enables reliable risk stratification.
Methods. Patients presenting to the emergency department
with a low to moderate probability of acute coronary syndromes
underwent rapid sestamibi injection with gated single-photon
emission computed tomographic imaging. Studies showing perfu-
sion defects with associated wall motion abnormalities were
considered positive.
Results. A total of 532 consecutive patients underwent serial
myocardial marker analysis and rest perfusion imaging. Of these
patients, perfusion imaging was positive in 171 (32%). Positive
perfusion imaging was the only multivariate predictor of myocar-
dial infarction (MI) (p < 0.0001, odds ratio [OR] 33, 95%
confidence interval [CI] 7.7 to 141) and was the most important
independent predictor of MI or revascularization (p < 0.0001, OR
14, 95% CI 7.3 to 25), followed by diabetes (p < 0.01, OR 2.8, 95%
CI 1.5 to 5.1), typical angina (p 5 0.01, OR 2.1, 95% CI 1.2 to 3.7)
and male gender (p 5 0.03, OR 1.9, 95% CI 1.1 to 3.5). The
sensitivity of positive perfusion imaging for MI was 93% (95% CI
77% to 98%), and for MI or revascularization it was 81% (95% CI
71% to 88%), with negative predictive values of 99% (95% CI 98%
to 100%) and 95% (95% CI 92% to 97%), respectively.
Conclusions. Positive rest perfusion imaging accurately identi-
fied patients at high risk for adverse cardiac outcomes, whereas
negative perfusion imaging identified a low risk patient group.
Early perfusion imaging allows for rapid and accurate risk
stratification of emergency department patients with possible
cardiac ischemia and nondiagnostic ECGs.
(J Am Coll Cardiol 1997;30:976–82)
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The evaluation of patients presenting to the emergency depart-
ment with chest pain is often problematic. Limitations in the
diagnostic accuracy of clinical, historic and electrocardio-
graphic (ECG) data result in the hospital admission of the
majority of these patients (1,2), even though many have
nonischemic etiologies for their chest pain (3,4). Despite this
low threshold for admission, 4% to 8% of patients with myocar-
dial infarction (MI) are inappropriately discharged from emer-
gency departments, often with adverse consequences (5,6).
Recent studies have used technetium-99m sestamibi (Car-
diolite, Dupont Pharma) in an effort to increase diagnostic
accuracy in patients presenting to the emergency department
with chest pain. Sestamibi has several advantages when used in
these patients, including minimal redistribution (7), which
allows patients to be injected while they are symptomatic and
to be imaged later after clinical stabilization. Initial studies
have demonstrated that sestamibi has a higher sensitivity and
specificity for detecting acute ischemic syndromes compared
with clinical and ECG variables (8–10). However, these studies
included relatively small numbers of patients who were selec-
tively enrolled in investigational protocols. The diagnostic
accuracy of rest sestamibi perfusion imaging when used in a
larger, nonselected patient group is unknown. The purpose of
this study was to determine the accuracy of early perfusion
imaging with sestamibi when used in patients considered to
have a low to moderate risk for acute coronary syndrome.
Methods
Patient selection. All patients who present to the Emer-
gency Department of the Medical College of Virginia/Virginia
Commonwealth University with symptoms suggestive of car-
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diac ischemia undergo prompt clinical evaluation, which in-
cludes a history, physical examination and ECG. Our chest
pain evaluation protocol has been previously described (11). In
general, high risk patients (those with abnormal ECGs or those
with nondiagnostic ECGs, known coronary disease and typical
symptoms) are admitted to the coronary care unit (CCU).
Lower risk patients undergo further risk stratification accord-
ing to a protocol that includes early rest myocardial perfusion
imaging. This study includes all patients who were evaluated in
the emergency department from June 1994 through August
1995, who underwent early perfusion imaging and serial myo-
cardial marker analysis. These guidelines were used by emer-
gency department residents and attending physicians for pa-
tient assessment, but clinical judgment was permitted,
occasionally resulting in the imaging of patients who retrospec-
tively did not meet these guidelines (21 patients with positive
and 26 patients with negative imaging results). Exclusion of
these patients did not significantly change the results, and
therefore they were included in all analyses.
Imaging and interpretation. The technique of early perfu-
sion imaging has been previously reported (11). Briefly, pa-
tients were injected with ;20 mCi of sestamibi in the emer-
gency department, and the presence or absence of symptoms
was recorded. Although patients were not required to be
symptomatic at the time of tracer injection, none were injected
more than 6 h after the last episode of pain. Approximately 60
to 90 min after injection, gated single-photon emission com-
puted tomographic (SPECT) myocardial perfusion imaging
was performed using a triple-headed gamma camera system.
Immediately after data acquisition, predefined commercial
protocols were used to generate short- and long-axis static
reconstructions and multilevel gated cine films for visual
interpretation.
Perfusion images were evaluated by an experienced nuclear
medicine attending physician, and all data were made available
to the physicians treating the patient. For purposes of this
study, images were classified as either positive or negative for
acute MI or ischemia. A positive study required a discrete
perfusion defect with associated abnormalities in wall motion
and thickening. Studies visually interpreted as normal, equiv-
ocal or consistent with cardiomyopathy were considered neg-
ative for acute coronary syndromes. Normal studies had nor-
mal perfusion and systolic function without regional wall
motion or thickening abnormalities. Equivocal studies typically
displayed low grade perfusion abnormalities but normal wall
motion and regional thickening. Studies consistent with car-
diomyopathy showed reduced systolic function on cinematic
replay with either normal perfusion or perfusion defects
without accompanying segmental wall motion abnormalities.
End points and definitions. The patients were observed in
the CCU and underwent serial sampling of myoglobin, creat-
ine kinase–MB fraction (CK-MB) mass and total creatine
kinase (CK). Decisions regarding further diagnostic evaluation
were made by the attending cardiologist in the CCU. Stress
testing was performed using either a standard Bruce protocol
or pharmacologic stress with dipyridamole or dobutamine.
Coronary angiography was performed using the Judkins tech-
nique with views of the coronary arteries obtained in multiple
projections. Significant coronary artery disease was defined as
$70% stenosis in a major coronary artery or its branches or
$50% left main coronary artery stenosis.
The primary end points were cardiac death, MI and revas-
cularization (coronary artery bypass graft surgery [CABG] or
percutaneous transluminal coronary angioplasty [PTCA]) dur-
ing the initial evaluation or within 5 days of admission.
Myocardial infarction was defined as CK-MB mass $8.0 ng/dl
with a relative index ([CK-MB mass/total CK] 3 100) $4.0.
For patients having both MI and revascularization, only MI
was counted as an event. Anginal symptoms were considered
typical if they were described as pressure, tightness, squeezing,
burning, heaviness, crushing or indigestion, or were similar to
previous symptoms of angina. Only the initial hospital admis-
sion was used for patients admitted more than once.
Statistical analysis. Results are presented as mean value 6
SD. Comparisons were made using the Student t test and
chi-square analysis for categoric and continuous variables,
respectively. A p value ,0.05 was considered significant.
Sensitivity, specificity and positive and negative predictive
values were calculated in the standard fashion. Stepwise logis-
tic regression analysis using the variables in Table 1 (age was
considered a dichotomous variable) was used to determine the
best model that predicted the specified clinical outcome.
Variables were entered into the model sequentially according
to the largest adjusted chi-square that had a p value #0.10 at
the specific step and were removed if the p value was $0.10.
Results
A total of 542 patients were observed in the CCU after
undergoing sestamibi injection in the emergency department.
Ten patients (1.9%) were excluded from the analysis (five
refused to be imaged and five had nondiagnostic image qual-
ity), leaving 532 patients in whom myocardial markers and
perfusion images could be compared. Perfusion imaging was
positive in 171 patients (32%) and negative in 361 (68%). The
negative studies consisted of 325 (90%) that were normal, 28
(7.8%) that were equivocal and 8 (2.2%) that were consistent
with cardiomyopathy. Comparisons of patients with positive
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CCU 5 coronary care unit
CI 5 confidence interval
CK 5 creatine kinase
ECG 5 electrocardiogram, electrocardiographic
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary
angioplasty
OR 5 odds ratio
SPECT 5 single-photon emission computed tomography
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and negative perfusion studies are shown in Table 1. Patients
with positive rest perfusion images were older and more likely
to be $60 years old, be male, have hypertension and diabetes
and have had a previous MI. They were also significantly more
likely to have a new MI (odds ratio [OR] 32, 95% confidence
intervals [CI] 7.5 to 137), to have an MI or undergo revascu-
larization (OR 15, 95% CI 8.5 to 28) or to have an MI,
revascularization or significant coronary artery disease (OR 17,
95% CI 10 to 28) (Fig. 1).
Myocardial infarction. Twenty-eight patients were diag-
nosed with MI (5.3%), 26 of whom (93%) had positive rest
perfusion images (Table 2). Only 2 (0.6%) of the 361 patients
(95% CI 0% to 2.4%) with negative perfusion images had an
acute MI. Both patients had non–Q wave MIs and both had
peak CKs ,500 U/liter and single-vessel disease.
Multivariate analysis demonstrated that positive rest perfu-
sion imaging was the only independent variable predictive of
MI (p , 0.001, OR 33, 95% CI 7.7 to 141). Early rest perfusion
imaging had a sensitivity of 93% (95% CI 77% to 98%), a
specificity of 71% (95% CI 66% to 74%) and a negative
predictive value of 99.4% (95% CI 98% to 100%) for identi-
fying or excluding MI. There was no significant difference in
the sensitivity for diagnosing MI in men compared with women
(94% vs. 92%).
Revascularization and coronary angiography. Ninety-two
patients who had positive rest perfusion imaging without a new
MI underwent coronary angiography. Significant disease was
found in 65 patients (71%), including 45 who then underwent
revascularization (CABG in 9, PTCA in 36). Among the 20
patients who were not revascularized, 7 had left main coronary
or three-vessel disease, 9 had two-vessel disease and four had
one-vessel disease. Seventy patients who had negative early
rest perfusion imaging also underwent diagnostic coronary
angiography; significant disease was found in 21 patients
(30%), 14 of whom underwent revascularization (CABG in 4,
PTCA in 10). Among the seven patients who were not revas-
cularized, six had single-vessel and one had three-vessel dis-
ease.
Patients with either MI or revascularization (n 5 87) were
compared with those with neither (n 5 445) (Table 3). Male
gender, diabetes, typical angina, previous MI and positive early
perfusion imaging were significantly more common in patients
with MI or revascularization. On multivariate analysis, positive
early perfusion imaging was the most important predictor (p ,
0.0001, OR 14), followed by diabetes (p , 0.01, OR 2.8),
typical angina (p 5 0.01, OR 2.1) and male gender (p 5 0.03,
OR 2.0) (Fig. 2). Positive early rest perfusion imaging had a
sensitivity of 82% (95% CI 71% to 88%), a specificity of 76%
(95% CI 72% to 80%) and a negative predictive value of 95%
(95% CI 92% to 97%) for predicting MI or revascularization.
There was no significant difference in the sensitivity when men
Table 1. Comparison of Patients With Positive and Negative Rest
Sestamibi Perfusion Imaging Studies
1 MIBI
(n 5 171)
2 MIBI
(n 5 361)
OR
(95% CI)* p Value*
Age (yr) 59 6 13 53 6 14 NA ,0.0001
Age $60 yr 82 (48%) 127 (35%) 1.7 (1.2–2.5) 0.005
Male gender 98 (57%) 144 (40%) 2.0 (1.4–2.9) 0.0002
Hypertension 121 (71%) 223 (62%) 1.5 (1.0–2.2) 0.04
Diabetes 53 (31%) 81 (22%) 1.6 (1.0–2.3) 0.04
Tobacco use 63 (37%) 151 (42%) 0.8 (0.6–1.2) 0.27
(1) family history 55 (32%) 124 (34%) 0.9 (0.6–1.3) 0.62
Elevated cholesterol 33 (19%) 59 (16%) 1.2 (0.8–1.6) 0.40
Total no. risk factors 1.9 6 1.1 1.8 6 1.1 NA 0.18
Typical chest pain† 88 (54%) 182 (52%) 1.1 (0.8–1.6) 0.60
Previous MI 70 (41%) 44 (12%) 5.0 (3.2–7.7) ,0.0001
Symptom duration
(h)
1 (0.3, 3) 1 (0.4, 3) — —
*Based on univariate analysis. †There were 162 patients with positive
sestamibi and 351 with negative sestamibi perfusion imaging studies for whom
chest pain characteristics were available. Data are presented as mean value 6
SD, number (%) of patients or median (25th, 75th percentiles). CI 5 confidence
interval; MI 5 myocardial infarction; MIBI 5 rest sestamibi perfusion imaging;
NA 5 not applicable; OR 5 odds ratio; (1) 5 positive.
Figure 1. Patient outcomes based on early rest perfusion imaging
results. The percentage of patients with positive perfusion imaging
(solid bars) who had myocardial infarction (MI), myocardial infarction
or revascularization (MI/R) and myocardial infarction, revasculariza-
tion or significant coronary disease (.70% stenosis) (MI/R/S) was
significantly higher than the percentage of patients with negative
perfusion imaging (open bars) for similar outcomes. All values were
significantly different at p , 0.0001.
Table 2. Comparison of Patients With and Without
Myocardial Infarction
With MI
(n 5 28)
Without MI
(n 5 504)
OR
(95% CI)* p Value*
Age (yr) 58 6 14 55 6 14 NA 0.22
Age $60 yr 12 (43%) 197 (39%) 1.2 (0.6–2.9) 0.22
Male 15 (54%) 227 (45%) 1.4 (0.7–3.0) 0.37
Hypertension 18 (64%) 326 (65%) 1.0 (0.5–2.2) 0.98
Diabetes 10 (36%) 124 (25%) 1.7 (0.8–3.8) 0.18
Tobacco use 10 (36%) 204 (40%) 0.8 (0.4–1.8) 0.63
(1) family history 8 (29%) 171 (34%) 0.8 (0.3–1.8) 0.57
Elevated cholesterol 3 (11%) 89 (18%) 0.6 (0.2–1.9) 0.35
Typical chest pain† 18 (64%) 252 (52%) 1.7 (0.8–3.7) 0.20
Total no. risk factors 1.8 6 1.0 1.8 6 1.1 NA 0.76
Previous MI 7 (25%) 106 (21%) 1.5 (0.6–3.5) 0.34
Positive sestamibi 26 (93%) 151 (30%) 31 (7.2–130) ,0.0001
*Based on univariate analysis. †There were 28 patients with myocardial
infarction and 485 patients without myocardial infarction for whom chest pain
characteristics were available for analysis. Data are presented as mean value 6
SD or number (%) of patients. Abbreviations as in Table 1.
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were compared with women (47 of 55 [86%] vs. 24 of 32 [75%],
p 5 0.28).
Twenty-seven of the 92 patients with positive early perfu-
sion images without a new MI underwent coronary angiogra-
phy but did not have significant coronary lesions (Table 4). Of
these, 18 patients had a history of MI. Two patients had at least
one vessel with 50% to 70% stenosis. In addition to the
perfusion imaging, four patients had either ECG or echocar-
diographic evidence consistent with an acute coronary syn-
drome, despite minimal disease on angiography. Thus, 24
(89%) of the 27 patients with abnormal perfusion images but
without angiographically significant coronary lesions had
symptoms or other diagnostic information, or both, consistent
with an acute coronary syndrome or previous MI.
Presence of chest pain at time of injection. Fourteen
(61%) of the 23 patients with negative rest perfusion imaging
who had an MI or significant disease were symptom free at the
time of injection. The sensitivity of positive early rest perfusion
imaging was not significantly different between patients in-
jected with and those injected without pain, regardless of which
end points were used: MI, revascularization or significant
coronary disease (82% vs. 86%); MI or revascularization (83%
vs. 78%); or revascularization or significant disease (76% vs.
73%).
Exclusion of patients with previous MI. Specificity may be
reduced by inclusion of patients with a previous MI. Therefore,
the data were reanalyzed after excluding the 114 patients with
historic or ECG evidence of a previous MI (70 positive and 44
negative). The only univariate predictor of MI remained
positive early rest perfusion imaging (p , 0.001, OR 78, 95%
CI 10 to 590). The sensitivity of positive early rest perfusion
imaging for predicting MI was essentially unchanged (95%;
95% CI 75% to 99%), and specificity significantly increased
from 71% to 80% (95% CI 79% to 87%, p 5 0.005). The
specificity for predicting MI or revascularization was also
significantly increased to 83% (95% CI 79% to 87%, p 5 0.01),
again without a significant change in sensitivity (78%; 95% CI
65% to 87%).
Discussion
We found that performing early rest myocardial perfusion
imaging in lower risk patients presenting to the emergencyFigure 2. Relative risks of the independent multivariate predictors of
MI or revascularization. DM 5 diabetes mellitus; (1) Mibi 5 positive
rest sestamibi perfusion imaging.
Table 4. Summary of False Positive Early Perfusion Imaging Studies
Based on Results of Coronary Angiography
No. of Pts Etiology of Positive Early Perfusion Imaging
18 Previous MI
12 Documented previous MI
4 Fixed defects on rest and stress perfusion imaging
2 Regional wall motion abnormalities on left ventriculography
2 Intermediate coronary lesion of 50% to 70%
4 Clinical scenario consistent with acute coronary syndrome
3 False positive results without apparent explanation
MI 5 myocardial infarction; Pts 5 patients.
Table 3. Comparison of Patients With and Without Myocardial Infarction or Revascularization
With MI or
Revascularization
(n 5 87)
Without MI or
Revascularization
(n 5 445)
OR
(95% CI)* p Value*
Age (yr) 58 6 13 54 6 14 NA 0.01
Age $60 yr 38 (44%) 171 (38%) 1.2 (0.7–1.8) 0.36
Male 53 (61%) 189 (42%) 2.1 (1.3–3.4) 0.002
Hypertension 63 (72%) 281 (63%) 1.5 (0.9–2.5) 0.10
Diabetes 37 (43%) 97 (22%) 2.7 (1.6–4.3) ,0.0001
Tobacco use 34 (39%) 180 (40%) 0.9 (0.6–1.5) 0.81
(1) family history 32 (37%) 147 (33%) 1.2 (0.7–1.9) 0.50
Elevated cholesterol 19 (22%) 73 (16%) 1.4 (0.8–2.0) 0.22
Total no. risk factors 2.1 6 1.2 1.7 6 1.0 NA 0.007
Typical chest pain† 52 (60%) 218 (51%) 1.8 (1.1–2.9) 0.02
Previous MI 29 (33%) 85 (19%) 2.1 (1.3–3.5) 0.003
Positive sestamibi 70 (81%) 107 (24%) 13.0 (7.3–23) ,0.0001
*Based on univariate analysis. †There were 81 patients with and 432 patients without myocardial infarction or
revascularization for whom chest pain characteristics were available for analysis. Data are presented as mean value 6 SD
or number (%) of patients. Abbreviations as in Table 1.
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department with possible myocardial ischemia accurately iden-
tified those at increased risk for cardiovascular complications.
Using multivariate analysis, positive perfusion imaging was the
only independent predictor of MI and was the most important
independent predictor of the combined end point of MI or
revascularization. The sensitivity for predicting MI or revascu-
larization was high, as was the negative predictive value for
excluding them. Excluding patients with a previous MI signif-
icantly improved the specificity for predicting MI alone and the
combination of MI or revascularization, with no loss in sensi-
tivity.
Each year ;6 million patients are evaluated in emergency
departments for chest pain or other symptoms consistent with
cardiac ischemia (1), accounting for 7% of all emergency
department visits (12). In patients with obvious ECG or clinical
indicators of cardiac ischemia, diagnosis and initial triage are
usually straightforward. In patients with nonischemic ECGs,
accurate diagnosis is more difficult. Although chest pain char-
acteristics, known coronary disease, age and gender have some
discriminating value (1,13–16), the overlap in initial presenta-
tions between patients with and those without cardiac ischemia
results in significant diagnostic uncertainty (1,2). This uncer-
tainty leads to the hospital admission of many patients whose
symptoms are ultimately attributed to nonischemic causes; the
cost for the evaluation of these patients is estimated to be $4
billion annually (17).
We found that early rest perfusion imaging was a powerful
predictor of MI in this patient group for which early and
accurate diagnosis has been difficult. Although the incidence of
MI in these patients is low, it is not insignificant (18,19) and is
associated with a clinically important mortality rate (4). Similar
to other studies, we found that traditional risk factors were not
helpful in distinguishing patients with MI (15,20–22).
Importantly, we found that early rest perfusion imaging
could accurately identify patients with acute ischemia without
MI. The importance of this identification is increasingly being
recognized. The number of patients admitted with unstable
angina has increased dramatically in recent years (23), ap-
proaching the numbers of patients admitted with MI (2,24).
Early recognition and aggressive medical management can
significantly reduce the high, short-term cardiovascular mor-
bidity and mortality of these patients (25,26). Although cardiac
markers may provide early diagnosis of patients with MI,
myocardial necrosis is necessary before the markers are re-
leased, so elevations will not be detectable in patients experi-
encing ischemia only. Even after MI is excluded, provocative
testing before discharge may be necessary to exclude signifi-
cant myocardial ischemia (27,28). Positive early perfusion
imaging has the advantage of providing early identification of
patients with ischemia, allowing rapid initiation of appropriate
treatment that may prevent the occurrence of MI.
Negative early perfusion imaging also provides important
prognostic information. Patients with negative rest perfusion
imaging can safely undergo early stress testing and therefore
be eligible for early discharge, potentially resulting in signifi-
cant cost savings. Although the initial costs of evaluating
patients with chest pain may increase because of expansion of
the emergency department coverage required for immediate
perfusion imaging, total costs may be decreased through
significant reductions in hospital resource costs (29,30).
In the current study, two patients with negative rest perfu-
sion imaging had MI. Although no previous study identified
MI in a patient with negative rest perfusion imaging, the upper
confidence limits (31) in the current study (2.4%) were con-
sistent with previous studies (8,9). Although SPECT imaging
can increase the sensitivity for diagnosing small infarcts over
that of planar imaging (32,33), all imaging techniques have
reduced sensitivities in patients with small or non–Q wave MIs
(34–36). The fact that some MIs may not be detected by early
perfusion imaging underscores the importance of using a
comprehensive multitiered diagnostic strategy, including se-
rum markers, rather than relying on a single diagnostic tool for
evaluating patients with a possible MI.
Pain versus pain-free injection. We found that sensitivity
did not significantly differ between patients who were and were
not experiencing symptoms at the time of injection. Other
studies have reported similar results. Varetto et al. (10) found
that sensitivity was high for diagnosing significant disease in
patients injected 2 to 8 h after symptom relief. Bilodeau et al.
(8) found that perfusion defects persisted in 17 (68%) of 25
patients who had an MI excluded and were restudied after
resolution of symptoms. Initial imaging studies using thallium-
201 for diagnosis of acute ischemia found a high sensitivity,
even though most patients were pain free at the time of
injection (37,38). However, in the current study, two-thirds of
the patients with negative rest studies who subsequently un-
derwent revascularization were injected while pain free. This
suggests that although the presence of symptoms is not always
necessary for demonstrating myocardial ischemia, provocative
testing may be required for optimal exclusion of unstable
angina in patients who were injected while pain free and who
had normal rest images.
Comparison with other studies. Our results are in agree-
ment with previous studies demonstrating that positive early
rest perfusion imaging accurately identifies patients who have
ongoing ischemia or infarction (8–10). In contrast, one study
found that early perfusion imaging had a low accuracy for
identifying patients at risk for MI (39). The lower specificity in
this study may have been due to the inclusion of a high
percentage of patients with a previous MI, a lack of gating of
images and use of planar imaging with a portable camera.
Our study differs from others in several important ways. We
evaluated a large number of unselected consecutive patients,
resulting in a more accurate estimate of the overall predictive
ability of early perfusion imaging. Despite using broad inclu-
sion criteria, we found sensitivities and specificities similar to
those of previous studies (8–10). Because all patients under-
went imaging as part of a systematic clinical protocol, biases
associated with preselecting patients were avoided, making the
results more representative of the capabilities of early perfu-
sion imaging in the clinical setting. Images were gated when-
ever possible, allowing simultaneous correlation of perfusion
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defects with wall motion abnormalities (40), thereby improving
specificity by identifying artifacts or tissue attenuation (41).
Study limitations. A limitation of early perfusion imaging
is the inability to differentiate between acute infarction, previ-
ous infarction and acute ischemia. Elevations in cardiac mark-
ers allow early identification of the patient with an acute
infarction. Discriminating among patients with ischemia and a
previous infarction may be more difficult. Although perfusion
defects are often seen in patients with a previous MI, consid-
ering them “false positive” results is not entirely correct; a
history of MI is an important risk factor in patients undergoing
evaluation for myocardial ischemia (1,14–16,20), and early
discharge is not usually appropriate. Appropriate clinical cor-
relation is often able to distinguish between those with and
those without a previous MI. Not all patients underwent
invasive testing, so the true sensitivity and specificity of early
perfusion imaging for identification of coronary disease were
not determined. However, the purpose of this study was to
evaluate the accuracy of early sestamibi perfusion imaging
when used in clinical practice, with all the inherent limitations.
We used revascularization as a surrogate for unstable angina,
an end point that has been used in previous studies of unstable
angina (42,43). Because physicians had knowledge of the
perfusion imaging results, a selection bias for angiographic
referral is possible. Despite this potential for bias, revascular-
ization implies the presence of significant coronary disease and
may provide a more objective end point for unstable angina
than the clinical diagnoses used in other studies.
Conclusions. We conclude that early rest perfusion imag-
ing using sestamibi in low to moderate risk patients with
nondiagnostic ECGs undergoing evaluation for possible myo-
cardial ischemia can successfully identify high and low risk
groups. Positive rest perfusion imaging predicted a high inci-
dence of MI or revascularization, whereas a negative study
identified patients with a low incidence of cardiovascular
complications. Further investigation is necessary to determine
if such a routine approach results in reduced costs compared
with current standard practice.
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